| human | Q5 |
| P496 | ORCID iD | 0000-0002-2833-2926 |
| P69 | educated at | University of Warwick | Q865528 |
| P108 | employer | Jenner Institute | Q5343754 |
| Health Protection Agency | Q5690635 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q33909667 | A molecular epidemiological investigation of Ascaris on Unguja, Zanzibar using isoenyzme analysis, DNA barcoding and microsatellite DNA profiling. |
| Q38636429 | A systematic review of quantitative burn wound microbiology in the management of burns patients |
| Q57077397 | An evaluation of the Mast D69C AmpC Detection Disc Set for the detection of inducible and derepressed AmpC -lactamases |
| Q37641378 | Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infection |
| Q37002434 | Antibacterial Activity of Blue Light against Nosocomial Wound Pathogens Growing Planktonically and as Mature Biofilms |
| Q41101388 | Antimicrobial dressings: Comparison of the ability of a panel of dressings to prevent biofilm formation by key burn wound pathogens |
| Q40375650 | Antimicrobial peptide coatings for hydroxyapatite: electrostatic and covalent attachment of antimicrobial peptides to surfaces. |
| Q34257253 | Assessment of humoral immune responses to blood-stage malaria antigens following ChAd63-MVA immunization, controlled human malaria infection and natural exposure |
| Q36903515 | Assessment of immune interference, antagonism, and diversion following human immunization with biallelic blood-stage malaria viral-vectored vaccines and controlled malaria infection |
| Q36460499 | ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans |
| Q39507421 | Changes in causes of acute gastroenteritis in the United Kingdom over 15 years: microbiologic findings from 2 prospective, population-based studies of infectious intestinal disease |
| Q35741984 | Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector |
| Q36871970 | Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01 |
| Q33974904 | Impact on malaria parasite multiplication rates in infected volunteers of the protein-in-adjuvant vaccine AMA1-C1/Alhydrogel+CPG 7909. |
| Q40791138 | In vitro activity of an engineered honey, medical-grade honeys, and antimicrobial wound dressings against biofilm-producing clinical bacterial isolates |
| Q90129034 | Loss of microbial diversity and pathogen domination of the gut microbiota in critically ill patients |
| Q35623459 | Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors |
| Q28731894 | Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors |
| Q37403767 | Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation |
| Q36255473 | Protocol for a systematic review of quantitative burn wound microbiology in the management of burns patients |
| Q39141393 | Reactive oxygen: A novel antimicrobial mechanism for targeting biofilm-associated infection |
| Q35767635 | The Antibacterial Activity of Acetic Acid against Biofilm-Producing Pathogens of Relevance to Burns Patients |
| Q39417659 | The contribution of leucocytes to the antimicrobial activity of platelet-rich plasma preparations: a systematic review |
| Q61446708 | The potential of visible blue light (405 nm) as a novel decontamination strategy for carbapenemase-producing enterobacteriaceae (CPE) |
| Q42256100 | Universal extraction method for gastrointestinal pathogens |
| Q38630881 | Use of an engineered honey to eradicate preformed biofilms of important wound pathogens: an in vitro study. |
Search more.